Loading clinical trials...

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGPHASE4

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

A Randomized Clinical Trial to Evaluate the Sedative Effect of the Combination of Remimazolam and Propofol in Drug-induced Sleep Endoscopy

NCT06784479•Dan Liu

View on ClinicalTrials.gov

Summary

This study helps patients find the optimal sedation regimen in drug-induced sleep endoscopy

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients diagnosed with sleep apnea hypopnea syndrome were included

Exclusion Criteria

•Patients were excluded if they had nasal obstruction, significantly deviated nasal septum, nasal turbinate hypertrophy, or nasal polyps. Patients with uncontrolled heart failure, renal insufficiency, diabetes, or hyperthyroidism were also excluded. Patients were also excluded if taking medications that could affect upper airway muscle function, such as ben- zodiazepines and muscle relaxants.

Locations (1)

Respiratory Endoscopy Center of Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

Key Dates

Start Date

March 1, 2025

Primary Completion Date

March 1, 2026

Completion Date

March 1, 2026

Last Updated

February 24, 2026

Enrollment

174

ACTUAL participants

Conditions

Sedative Effect During Drug-induced Sleep EndoscopyObstructive Sleep Apnea (OSA)

Interventions

Remimazolam and Propofol

DRUG

Propofol

DRUG

Midazolam and propofol

DRUG

Digital-supported Orofacial Myofunctional Therapy in OSA

NCT07292922

Obstructive Sleep Apnea (OSA)

View study

RECRUITING

A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores

NCT06861686

Obstructive Sleep Apnea (OSA)

View study

RECRUITINGNA

IOA Preventing Occlusal Changes With MAD Use

NCT07103941

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

Inclusion Criteria

Exclusion Criteria

Digital-supported Orofacial Myofunctional Therapy in OSA

A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores

IOA Preventing Occlusal Changes With MAD Use

Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal

Optic Nerve Injury in Obstructive Sleep Apnea Patients

Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea